MAYO CLINIC HOSPITAL ROCHESTER — History
CCN 240010 | 3-year financial timeline | COVID resilience: 72/100
🛡️ Public data only — no PHI permitted on this instance.
$3.4B
Latest Revenue (FY2022)
+10.2%
Revenue CAGR (3yr)
31.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $2.8B | $3.3B | $3.4B | +3.8% | +10.2% |
| Operating Expenses | $2.0B | $2.3B | $2.3B | +3.4% | +7.6% |
| Operating Margin | 28.5% | 31.6% | 31.8% | +0.8% | +5.7% |
| Net Income | $808M | $1.0B | $1.1B | +4.7% | +16.4% |
| Licensed Beds | 1,111 | 1,143 | 1,157 | +1.2% | +2.0% |
| Total Patient Days | 270,014 | 311,582 | 328,079 | +5.3% | +10.2% |
| Medicare Day % | 36% | 35% | 33% | -4.7% | -3.7% |
| Medicaid Day % | 13% | 16% | 14% | -8.6% | +3.0% |
COVID Impact & Recovery
Resilience Score: 72/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +21.4% ($2.8B → $3.4B)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+10.2%
This Hospital
+7.6%
State Avg
Latest Margin
31.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $3.7B | 33.5% |
| FY2024 (proj) | $4.1B | 35.1% |
| FY2025 (proj) | $4.4B | 36.8% |